Nuclear receptors, testosterone, and posttranslational modifications in human INSL3 promoter activity in testicular leydig cells

Annals of the New York Academy of Sciences

Volumn 1160, Issue , 2009, Pages 205-212

  Tremblay, Jacques J ^a,b   Robert, Nicholas M ^a   Laguë, Éric ^a  

^a University Laval   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Acetylation; Androgens; Male sex differentiation; NUR77; Phosphorylation; Relaxin like factor; SF1; Testis descent

Indexed keywords

CELL NUCLEUS RECEPTOR; HORMONE; INSULIN LIKE PEPTIDE 3; NUCLEAR RECEPTOR NUR77; TESTOSTERONE; UNCLASSIFIED DRUG;

ACETYLATION; BINDING SITE; CONFERENCE PAPER; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INSL3 GENE; LEYDIG CELL; MALE; PROMOTER REGION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; SEX DIFFERENTIATION; TESTIS DESCENT;

MAMMALIA;

EID: 64549156508     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2008.03807.x     Document Type: Conference Paper

References (47)

1. Adham, I.M., E. Burkhardt, M. Benahmed, et al. 1993. Cloning of a cDNA for a novel insulin-like peptide of the testicular Leydig cells. J. Biol. Chem. 268: 26668-26672.
2. Pusch, W., M. Balvers & R. Ivell. 1996. Molecular cloning and expression of the relaxin-like factor from themousetestis. Endocrinology 137: 3009-3013.
3. Balvers, M., A.N. Spiess, R. Domagalski, et al. 1998. Relaxin-like factor expression as a marker of differentiation in the mouse testis and ovary. Endocrinology 139: 2960-2970.
4. Zimmermann, S., P. Schottler, W. Engel, et al. 1997. Mouse Leydig insulin-like (Ley I-L) gene: Structure and expression during testis and ovary development. Mol. Reprod. Dev. 47: 30-38.
5. Nef, S. & L.F. Parada. 1999. Cryptorchidism in mice mutant for Ins13. Nat. Genet. 22: 295-299.
6. Zimmermann, S., G. Steding, J.M. Emmen, et al. 1999. Targeted disruption of the Ins13 gene causes bilateral cryptorchidism. Mol. Endocrinol. 13: 681-691.
7. Bullesbach, E.E., R. Rhodes, B. Rembiesa, et al. 1999. The relaxin-like factor is a hormone. Endocrine 10: 167-169.
8. Kawamura, K., J. Kumagai, S. Sudo, et al. 2004. Paracrine regulation of mammalian oocyte maturation and male germ cell survival. Proc. Natl. Acad. Sci. USA 101: 7323-7328.
9. Irving-Rodgers, H.F., R.A. Bathgate, R. Ivell, et al. 2002. Dynamic changes in the expression of relaxin-like factor (INSL3), cholesterol side-chain cleavage cytochrome P450, and 3β-hydroxysteroid dehydrogenase in bovine ovarian follicles during growth and atresia. Biol. Reprod. 66: 934-943.
10. Spanel-Borowski, K., I. Schafer, S. Zimmermann, et al. 2001. Increase in final stages of follicular atresia and premature decay of corpora lutea in Ins13-deficient mice. Mol. Reprod. Dev. 58: 281-286.
11. Ferlin, A., A. Pepe, L. Gianesello, et al. 2008. Mutations in the insulin-like factor 3 receptor are associated with osteoporosis. J. Bone Miner. Res. 23: 683-693.
12. Koskimies, P., J. Levallet, P. Sipila, et al. 2002. Murine relaxin-like factor promoter: functional characterization and regulation by transcription factors steroidogenic factor 1 and DAX-1. Endocrinology 143: 909-919.
13. Zimmermann, S., A. Schwarzler, S. Buth, et al. 1998. Transcription of the Leydig insulin-like gene is mediated by steroidogenic factor-1. Mol. Endocrinol. 12: 706-713.
14. Sadeghian, H., R. Anand-Ivell, M. Balvers, et al. 2005. Constitutive regulation of the Ins13 gene in rat Leydig cells. Mol. Cell. Endocrinol. 241: 10-20.
15. Truong, A., N.V. Bogatcheva, C. Schelling, et al. 2003. Isolation and expression analysis of the canine insulin-like factor 3 gene. Biol. Reprod. 69: 1658-1664.
16. Robert, N.M., L.J. Martin & J.J. Tremblay. 2006. The orphan nuclear receptor NR4A1 regulates insulin-like 3 gene transcription in Leydig cells. Biol. Reprod. 74: 322-330.
17. Tremblay, J.J. & N.M. Robert. 2005. Role of nuclear receptors in INSL3 gene transcription in Leydig cells. Ann. N. Y. Acad. Sci. 1061: 183-189.
18. Val, P., A.M. Lefrancois-Martinez, G. Veyssiere, et al. 2003. SF-1: A key player in the development and differentiation of steroidogenic tissues. Nucl. Recept. 1:8.
19. Eells, J.B., J. Witta, J.B. Otridge, et al. 2000. Structure and function of the Nur77 receptor subfamily, a unique class of hormone nuclear receptor. Curr. Genomics 1: 135-152.
20. Maxwell, M.A. & G.E. Muscat. 2005. The NR4A subgroup: Immediate early response genes with pleiotropic physiological roles. Nucl. Recept. Signal. 4: 1-8.
21. Bassett, M.H., T. Suzuki, H. Sasano, et al. 2004. The orphan nuclear receptor NGFIB regulates transcription of 3β-hydroxysteroid dehydrogenase. Implications for the control of adrenal functional zonation. J. Biol. Chem. 279: 37622-37630.
22. Havelock, J.C., A.L. Smith, J.B. Seely, et al. 2005. The NGFI-B family of transcription factors regulates expression of 3β-hydroxysteroid dehydrogenase type 2 in the human ovary. Mol. Hum. Reprod. 11: 79-85.
23. Martin, L.J. & J.J. Tremblay. 2005. The human 3β-hydroxysteroid dehydrogenase/5-4 isomerase type 2 promoter is a novel target for the immediate early orphan nuclear receptor NUR77 in steroidogenic cells. Endocrinology 146: 861-869.
24. Zhang, P. & S.H. Mellon. 1997. Multiple orphan nuclear receptors converge to regulate rat P450c17 gene transcription: Novel mechanisms for orphan nuclear receptor action. Mol. Endocrinol. 11: 891-904.
25. Hong, C.Y., J.H. Park, R.S. Ahn, et al. 2004. Molecular mechanism of suppression of testicular steroido-genesis by proinflammatory cytokine tumor necrosis factor alpha. Mol. Cell. Biol. 24: 2593-2604.
26. 2+/calmodulin-dependent protein kinase 1. Mol. Endocrinol. 22: 2021-2037.
27. Hammer, G.D., I. Krylova, Y. Zhang, et al. 1999. Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: Integration of hormone signaling in reproduction and stress. Mol. Cell 3: 521-526.
28. Chen, W.Y., L.J. Juan & B.C. Chung. 2005. SF-1 (nuclear receptor 5A1) activity is activated by cyclic AMP via P300-mediated recruitment to active foci, acetylation, and increased DNA binding. Mol. Cell. Biol. 25: 10442-10453.
29. Jacob, A.L., J. Lund, P. Martinez, et al. 2001. Acetylation of steroidogenic factor 1 protein regulates its transcriptional activity and recruits the coactivator GCN5. J. Biol. Chem. 276: 37659-37664.
30. Davis, I.J., T.G. Hazel, R.H. Chen, et al. 1993. Functional domains and phosphorylation of the orphan receptor Nur77. Mol. Endocrinol. 7: 953-964.
31. Hirata, Y., K. Kiuchi, H.C. Chen, et al. 1993. The phosphorylation and DNA binding of the DNA-binding domain of the orphan nuclear receptor NGFI-B. J. Biol. Chem. 268: 24808-24812.
32. Eacker, S.M., J.E. Shima, C.M. Connolly, et al. 2007. Transcriptional profiling of androgen receptor (AR) mutants suggests instructive and permissive roles of AR signaling in germ cell development. Mol. Endocrinol. 21: 895-907.
33. O'Shaughnessy, P.J., H. Johnston, L. Willerton, et al. 2002. Failure of normal adult Leydig cell development in androgen-receptor-deficient mice. J. Cell Sci. 115: 3491-3496.
34. Foresta, C., A. Bettella, C. Vinanzi, et al. 2004. A novel circulating hormone of testis origin in humans. J. Clin. Endocrinol. Metab. 89: 5952-5958.
35. De, R.G., F. Aniello, M. Branno, et al. 2006. The expression level of frog relaxin mRNA (fRLX), in the testis of Rana esculenta, is influenced by testosterone. J. Exp. Biol. 209: 3806-3811.
36. Comhaire, F.H. & A. Vermeulen. 1976. Testosterone concentration in the fluids of seminiferous tubules, the interstitium and the rete testis of the rat. J. Endocrinol. 70: 229-235.
37. Lagü e, E. & J.J. Tremblay. 2008. Antagonistic effects of testosterone and the endocrine disruptor mono-(2- ethylhexyl) phthalate on INSL3 transcription in Leydig cells. Endocrinology 149: 4688-4694.
38. Wilson, T.E., T.J. Fahrner & J. Milbrandt. 1993. The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction. Mol. Cell. Biol. 13: 5794-5804.
39. Roche, P.J., S.A. Hoare & M.G. Parker. 1992. A consensus DNA-binding site for the androgen receptor. Mol. Endocrinol. 6: 2229-2235.
40. Rahman, F. & H.C. Christian. 2007. Non-classical actions of testosterone: an update. Trends Endocrinol. Metab. 18: 371-378.
41. Cheng, J., S.C. Watkins & W.H. Walker. 2007. Testosterone activates mitogen-activated protein kinase via Src kinase and the epidermal growth factor receptor in Sertoli cells. Endocrinology 148: 2066-2074.
42. Han, Y.H., X. Cao, B. Lin, et al. 2006. Regulation of Nur77 nuclear export by c-Jun N-terminal kinase and Akt. Oncogene 25: 2974-2986.
43. Yang, G.S., R.K. Lu & Z.D. Chen. 2002. Clinical significance of EGF and EGFR expression changes in cryptorchid boys. Asian J. Androl. 4: 255-258.
44. Li, Y. & L.F. Lau. 1997. Adrenocorticotropic hormone regulates the activities of the orphan nuclear receptor Nur77 through modulation of phosphorylation. Endocrinology 138: 4138-4146.
45. Yazdanbakhsh, K., J.W. Choi, Y. Li, et al. 1995. Cyclosporin A blocks apoptosis by inhibiting the DNA binding activity of the transcription factor Nur77. Proc. Natl. Acad. Sci. USA 92: 437-441.
46. Li, A., Y. Xue, C. Jin, et al. 2006. Prediction of N-acetylation on internal lysines implemented in Bayesian discriminant method. Biochem. Biophys. Res. Commun. 350: 818-824.
47. Shalizi, A., B. Gaudilliere, Z. Yuan, et al. 2006. A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation. Science 311: 1012-1017.